Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer.
about
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issuesMultifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilitiesControlled Drug Release from Pharmaceutical NanocarriersNanotechnology and HIV: potential applications for treatment and prevention.Progress in antiretroviral drug delivery using nanotechnologyA review of nanotechnological approaches for the prophylaxis of HIV/AIDS.Current approaches to enhance CNS delivery of drugs across the brain barriersGlycopeptide dendrimers. Part II.Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes.Nanoparticle-based drug delivery to the vagina: a review.Antiretroviral therapy in macrophages: implication for HIV eradication.Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapiesExploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics.Nanotechnology and the treatment of HIV infection.Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.Glycopeptide dendrimers, part III: a review. Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases.Targeting anti-HIV drugs to the CNS.Surface-engineered dendrimers: a solution for toxicity issues.Dendrimers as therapeutic agents: a systematic review.Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs.Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.Receptor-based targeting of therapeutics.Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology.Dendritic glycopolymers based on dendritic polyamine scaffolds: view on their synthetic approaches, characteristics and potential for biomedical applications.Nano-ART and NeuroAIDS.Nanosilver based anionic linear globular dendrimer with a special significant antiretroviral activity.Formulation development and in vitro-in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector.Surface structured liposomes for site specific delivery of an antiviral agent-indinavir.In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis.Formulation and evaluation of ethosomes for transdermal delivery of lamivudine.Effects of dendritic core-shell glycoarchitectures on primary mesenchymal stem cells and osteoblasts obtained from different human donorsEnhanced anti-HIV efficacy of indinavir after inclusion in CD4-targeted lipid nanoparticles.Design and characterization of novel peptide-coated lipid nanoparticles for targeting anti-HIV drug to CD4 expressing cells.Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles.Studying complexes between PPI dendrimers and Mant-ATP.The influence of densely organized maltose shells on the biological properties of poly(propylene imine) dendrimers: new effects dependent on hydrogen bonding.Development of peptide inhibitors of HIV transmission.Harnessing nanostructured systems for improved treatment and prevention of HIV diseaseDendrimers as topical microbicides with activity against HIV
P2860
Q26825175-80CDFCC9-A7D1-4F65-8627-8C09C04CDE3BQ27011598-1420E01B-2B5F-4F9C-AE6F-255B0A908AE4Q28257050-D0B0E41B-EC02-4CE5-8EC9-C4EA51F01F69Q30393980-7F4DECD3-62BF-4C88-91F2-2A403B03BE38Q30395011-D7CCA908-098B-4E02-8DDD-FE853E6CB51CQ30431343-F27E7FD9-074A-44E0-97ED-550BEA9DC11FQ30437835-2253E309-9D6C-4C82-81B1-434D22E00FECQ33306559-D012E238-D464-4177-A2AF-7547942A0CEBQ33819656-5E1E93E8-8FB8-43DE-8E85-77B99780C708Q33838871-F89AE233-15B9-4772-B3AF-6DA7A38A5979Q34079533-8C3B7CEC-99ED-4658-ABB2-CCCBA2ED3DBAQ34298792-80F7339C-DE8D-4966-B4FB-8BD587EC8267Q34797004-806F2514-92A1-4428-8D00-F7B0A19FDD1BQ34827321-6674E078-D510-4182-AFC7-69F03B796745Q35943647-2D50214E-9920-4880-AC0A-71F94C2FECB8Q37003811-3D281B69-563A-47E8-89A3-AF3899206D7EQ37084775-2F4598B4-809B-4891-A6C9-06A41F017F4FQ37368323-FF2D3DEA-E649-424F-B328-ABE96FD3DDC9Q37372870-87C6390A-29C2-4947-976C-0A49849563D9Q37585659-6D634A69-7D6B-486C-AF0B-3B12975EFD13Q37639557-502DA359-6D9C-4BBB-9C28-0BD28689676CQ37823446-B58F6403-A892-441D-B54A-575B9700375CQ38084739-906A8A1B-F6AC-4F31-8FBC-2D4A2DE1B2E7Q38285751-EF09E33B-CEB0-431C-A766-7E5322F3A9D9Q38292341-50E3774C-848D-4AF6-B3E3-9F388C86DC9AQ38823456-B772EA0F-87B8-45D7-8547-D439A8651227Q39016168-ECD5A610-A0D3-4CBF-B005-CCCBFBB6A036Q39018790-99773BBA-F01F-4142-A77F-EC03B0EA333CQ39684031-9A365319-B663-4C6C-B7E5-0290C252E009Q39819371-F73ED571-CE45-4574-A9FF-7C679DC6F3A6Q40027373-49D25B54-8F37-4632-97F6-0CCABFA110FAQ41134299-A793E575-E4F1-4BEF-8AA9-A810FF323C0BQ41822791-9306FE47-FCBB-47EC-A023-3C2215807BF2Q41951619-B3A02333-2166-4ACD-9C8D-684C19DED20EQ43258446-B260A15A-ED8A-4EC9-B61C-527FDFCDB75EQ43737928-B45CD57D-D463-4BDF-8B6E-9ED0B930131EQ46521501-A55AE261-F4F5-4350-ACA8-B9E48A05508CQ55317261-34757FCE-E3D4-4138-AC8F-BCD3ED01E8AFQ56992437-7DAF3297-88F7-47B8-A1E7-5EB90050204AQ57079961-220C4A11-48FB-4E2D-9DBF-FBF7DD03AD19
P2860
Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Targeting potential and anti-H ...... ly (propyleneimine) dendrimer.
@en
type
label
Targeting potential and anti-H ...... ly (propyleneimine) dendrimer.
@en
prefLabel
Targeting potential and anti-H ...... ly (propyleneimine) dendrimer.
@en
P1476
Targeting potential and anti-H ...... ly (propyleneimine) dendrimer.
@en
P2093
Narendra K Jain
Tathagata Dutta
P304
P356
10.1016/J.BBAGEN.2006.12.007
P577
2006-12-21T00:00:00Z